ONO-2910
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ONO-2910, covering 2024-05-03 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel [Phase 2]